For adults in midlife, CDC data establish subjective cognitive decline (SCD) — self-reported worsening confusion or memory loss — as common and risk-related. Progression to mild cognitive impairment or dementia remains uncertain for any one person. Midlife matters because earlier discussion allows testing, planning, and support. The 2026 public-health message centers on prompt clinical conversation and community links.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How public health tracks memory concerns
- How common SCD was in 2023
- Why midlife is not too early
- What to do about worsening memory now
How public health tracks memory concerns
CDC tracks SCD through the BRFSS 6-question Cognitive Decline module, according to the CDC Healthy Aging Data page. It records self-reported confusion or memory loss happening more often or getting worse in the past 12 months among adults age 45 and older.
The measure relies on state-based telephone self-reports without cognitive testing. CDC methodology notes this cross-sectional design cannot prove cause, confirm dementia, or predict who will progress.
How common SCD was in 2023
Using 2023 BRFSS data from adults age 45 and older, the CDC Division of Population Health reports overall SCD prevalence was 16.9%, in the 2023 national SCD study. The 95% confidence interval was 16.5-17.3.
Among adults with SCD in that national sample, the same CDC study reports 59.3% felt worried but only 42.8% had discussed it with a health care provider. The gap matters because worry without discussion delays evaluation and planning.
Why midlife is not too early
SCD affects midlife adults, not only older adults. The CDC MMWR analysis of 2015-2020 data found age-adjusted prevalence of 9.6% at age 45 and older, with highest prevalence in American Indian/Alaska Native adults at 16.7%. Research cited in 2025 reported 10.8% in ages 45-64 and 11.7% in ages 65 and older.
A 2025 Preventing Chronic Disease study of 35,754 adults 45 and older establishes SCD as an early indicator and risk factor for possible future mild cognitive impairment and dementia, not a diagnosis itself. Worry and functional difficulty raise concern within that risk signal. Forgetting a name once differs from losing track of bills, medications, or familiar routes.
What to do about worsening memory now
For action in 2026, CDC and the Alzheimer's Association's Healthy Brain Initiative State and Local Road Map for Public Health, 2023-2027 prescribes 24 public-health actions, described in the Healthy Brain Initiative Road Map. The actions cover brain health, early detection, caregiving, and equity.
For readers, public-health guidance points to prompt steps: The Alzheimer's Association 2026 Alzheimer's Disease Facts and Figures reports about 7.4 million Americans age 65 and older living with Alzheimer's dementia. Against that backdrop, adults in midlife with worsening symptoms should seek clinical discussion promptly and bring two recent examples to that visit.
- Track when confusion or memory loss happens more often or gets worse
- Schedule a prompt visit with a clinician to discuss symptoms
- Bring examples of daily tasks that have become harder
- Ask about community-clinical supports for brain health and caregiving
You Might Also Like
- Dementia Subtype Data Gaps Identified by NIA in 2026: What Is Established and What Remains Uncertain for Adults With Memory Concerns
- Privacy and Data Access Gaps in 2026 Dementia Research: What Is Established and What Remains Uncertain for Adults With Memory Concerns
- Maine’s 2026 ECHO Training for Dementia Risk Reduction: What Is Established and What Remains Uncertain for Adults in Midlife





